Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$2.17
-4.20%today
MKT CAP
$792M
-12.1% · 1Y
Earnings History
+5.1%
+17.2%
+18.7%
+22.5%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$2.17
Low
$3.85
Analyst Mean
$8.65
High
$14.00
12 analystsNone
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-2.0x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-53.4%
Debt / Equity28.46x
Free Cash Flow$-80,727,000
Insider Ownership11.1%
Institutional Ownership48.1%
Short % of Float17.69%
Days to Cover2.5d
1 Week-2.3%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| YOSHIYAMA ANNIE | Officer | Sale | 9,586 | $2.31 | $0.02M | 2026-04-21 |
| BENESKI BENJAMIN MACHINAS | Chief Technology Officer | Sale | 2,867 | $2.50 | $0.01M | 2026-03-31 |
| CHANG DAVID D | Chief Executive Officer | Sale | 47,763 | $2.47 | $0.12M | 2026-03-16 |
| BENESKI BENJAMIN MACHINAS | Chief Technology Officer | Sale | 4,835 | $2.47 | $0.01M | 2026-03-16 |
| BENESKI BENJAMIN MACHINAS | Chief Technology Officer | Sale | 7,132 | $2.60 | $0.02M | 2026-03-02 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Pfizer Inc | institution | 9.00% | $0.05B | +0.00% | 2025-12-31 |
| TPG GP A, LLC | institution | 7.65% | $0.04B | +0.00% | 2025-12-31 |
| Blackrock Inc. | institution | 7.22% | $0.04B | +0.92% | 2025-12-31 |
| Citadel Advisors Llc | institution | 4.95% | $0.03B | -13.31% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.78% | $0.02B | +2.56% | 2025-12-31 |
| Primecap Management Company | institution | 3.32% | $0.02B | +14.98% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 2.23% | $0.01B | +100.00% | 2026-03-31 |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | fund | 2.12% | $0.01B | +17.92% | 2025-12-31 |
| Patient Square Capital LP | institution | 2.03% | $0.01B | +66.49% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 1.99% | $0.01B | -0.13% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 1.61% | $0.01B | +2.58% | 2025-12-31 |
| Frazier Life Sciences Management, L.P. | institution | 1.58% | $0.01B | +0.00% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.55% | $0.01B | +0.68% | 2026-03-31 |
| Woodline Partners LP | institution | 1.43% | $0.01B | -19.72% | 2025-12-31 |
| PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund | fund | 1.13% | $0.01B | +1.09% | 2026-03-31 |
| T. Rowe Price Health Sciences Fund, Inc. | fund | 0.88% | $0.00B | -17.75% | 2025-12-31 |
| abrdn Life Sciences Investors | fund | 0.85% | $0.00B | +31.86% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.74% | $0.00B | +6.78% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.62% | $0.00B | +0.21% | 2026-02-28 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | fund | 0.57% | $0.00B | +0.00% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for ALLO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.